[Circulating troponin I assay: uses and misuses in medical practice].
Cardiac troponin I (cTnI) contributes to the modulation of the myocardial contractile function in the troponins complex. The assay of circulating cTnI is highly specific of the cardiac isoform and allows a quantification of the myocardial injury provided that both free and combined cTnI were recognized by the antibodies. The assay is a major contribution to the diagnosis of postoperative cardiac complications through its specificity because peripheral muscle trauma is a confounding factor during this period. Circulating cTnI mirrors the magnitude of an acute circulatory failure whatever the origin (cardiac, hemorrhagic or septic). A positive cTnI assay in an "asymptomatic" patient has to be confirmed and needs some investigations to discard an occult cardiac disease; cTnI has a limited role by itself in predicting mortality and hospital admissions. Circulating cTnI confirms the severity of an acute coronary syndrome and has a level-dependent prognostic value.